Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition

15 Nov 2014

Abstract excerpt

// Rebecca Lamb 1,2 , Hannah Harrison 1,2 , James Hulit 1,2 , Duncan L. Smith 3 , Michael P. Lisanti 1,2 and Federica Sotgia 1,2 1 The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University of Manchester 2 The Breakthrough Breast Cancer Research Unit, Institute of Cancer Sciences, University of Manchester 3 The Cancer Research UK Manchester Institute, University of Manchester...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Diet and metabolism studies
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25415228
DOI: 10.18632/oncotarget.2789

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibitionPMID 25415228Read ↗

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistantSemantic proximity Read ↗

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cellsSemantic proximity Read ↗

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signalingSemantic proximity Read ↗

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial EnergySemantic proximity Read ↗

Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)Semantic proximity Read ↗

Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancerSemantic proximity Read ↗

Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancerSemantic proximity Read ↗

Targeted Anti-Mitochondrial Therapy: The Future of OncologySemantic proximity Read ↗

Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer*Semantic proximity Read ↗

Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistanceSemantic proximity Read ↗

Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survivalSemantic proximity Read ↗

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.